¡°	cefadroxil monohydrate	22.17082873746401
¡°	ingested cefadroxil DC	16.260656948754164
¡°	cefadroxil DC convert	15.05279097540875
	Bouzard crystal	12.608119927755105
¡°	Bouzard monohydrate	10.193465130789793
¡°	chemical compound cefadroxil	9.267360999028126
	Cefadroxil DC	4.419497511285529
	Gema affiliate	2.188413127222985
	Gema effort	1.5948341961875048
	antibiotic crystal	1.242293887231667
	ingestion	1.0839968217771392
	complaint	1.0596031410851243
	chemist	0.9587030767696373
	theory	0.9541980394563022
	following x ray diffraction property	0.8704417438663538
	pre ingested form	0.7430023273922672
	penicillin	0.7126728598434589
	hemihydrate form	0.712090146646874
	pre ingested powdered form	0.648120406519424
	preingestation encapsulation	0.5734092624951151
	Inc. commercial sale	0.45432693394015905
	seller	0.42484793145711514
	Barcelona	0.4110885486356052
	vivo conversion issue	0.32771615217831396
	Spada	0.2865663890104227
	cephalosporin family	0.2468380050609332
	transitory chemical change	0.2427425421842956
	spanish company	0.23817792076830815
	manufactured state	0.23755762519425802
	four count	0.23507935837498806
	capsule	0.21716419320391595
	patient stomach	0.2112808519914822
	Civil Action No. HAR	0.19502663409727874
	drug preingeste form	0.18652349752953795
	commercially useful crystalline form	0.1702898761320139
	abbreviated approval	0.16586849110540022
	remain count	0.1565741074339938
	infringement count	0.15656239446700523
	bacteria	0.14173516583196216
	Maryland action	0.11705882528538715
	prior consent decree	0.10473511211821568
	fifth still pende count	0.10466267248992452
	relative intensity	0.10361092969596541
	solubility	0.08790478356009927
	additional infirmity	0.08638866703725923
	FDA regulation	0.0700856715868726
	E.I. Du Pont de Nemours	0.06650676587857547
	FDA approval	0.06571402901166346
	bulk density	0.06267867336971632
	coverage	0.060750106836510234
	reconsideration	0.055658885219180325
	manufacturing benefit	0.049386986039099405
	settlement	0.04848214176822057
	antitrust violation	0.047194695025476935
	various scan	0.04404335184283105
	prior compound	0.04331378457892354
	drug compound	0.03999964173879075
	New Jersey	0.0390004178103041
	unfair competition	0.03462899614413754
	stability	0.0330664311159009
	superior manufacturing relate benefit	0.032847083373911005
	manufacturing relate characteristic	0.0320029438501321
	relation	0.029849821121932223
	know compound	0.02887788774038362
	stipulation	0.027841155339340697
	allowance	0.025462301656309628
	commercial distribution	0.01791883643817044
	active ingredient	0.01728439245501898
	exclusive United States distributor	0.014421392030248132
	commercial marketing	0.014207338532814275
	chemical property	0.013777443861350845
	declaratory judgment suit	0.012825221446992904
	plan	0.012821717652594282
	propose restriction	0.012672561530970036
	suggest restriction	0.012557858957859084
	Civil Procedure	0.012317053040276523
	expiration date	0.011093827925423473
	previous dismissal	0.010641500501544278
	prosecution history estoppel	0.01048078360671196
	equivalent	0.009643538747505828
	certain characteristic	0.00932675582964311
	medical treatment	0.00848806320364109
	Federal Rules	0.008215068426836104
	present declaratory judgment action	0.007683728226166089
	difficulty	0.007541092133593598
	human body	0.0071269509510283055
	task	0.007098696034679891
	S.A.	0.005650193449810712
	mind	0.005341163393681116
	literal infringement	0.005313857057770987
	Food Drug Administration	0.005269968421248402
	relevance	0.0037721329971464974
	proof	0.0037384285729545746
	March	0.0036121844227668515
	term property	0.0032530258640229687
	August	0.0030431838762314638
	commercial production process	0.002634002104245086
	plaintiff	0.0024933339221171248
	oral hearing	0.002282836113923279
	bench trial	0.0021845959491375486
	sole	0.002072593967246554
	two declaration	0.002064771827607855
	June	0.0019462226267071027
	accordance	0.0018609024614656268
	II	0.0018490461557861392
	anything	0.0017694288972816606
	structural distinction	0.0017338907419757845
	doctrine	0.0012410176850675288
	December	0.0011867928540811679
	thus sale	0.0010773315598885669
	July	0.0009735208720353545
	April	0.0009265546739640172
	phrase	0.0008393411988581647
	May	0.0007988653998321922
	owner	0.0007571331960557634
	genuine dispute	0.0006828956579691621
	reverse	0.0006353850338252517
	prior litigation	0.000627615568569762
	effective date	0.000578361240757187
	October	0.0005374803012635372
	five separate ground	0.0005163487022984166
	genuine factual dispute	0.0005145125227299107
	nothing	0.00047857884716187105
	patentability	0.0004186269796804907
	absence	0.0003468422620764947
	problem	0.00032244337715208805
	patented product	0.000267713650752685
	statement	0.0002502518640824735
	cross motion	0.00020308718867216062
	summary judgment	0.00014797367989706354
	validity	6.450848123145943e-05
	legal issue	4.7878148104064336e-05
	particular word	4.371820375602862e-05
	original	4.227057689215358e-05
	two ground	3.196236998766498e-05
	way	2.9353228537068645e-05
	prior form	2.4887108083897065e-05
	view	2.3042507691989513e-05
	single	1.695095476109582e-05
	construction	1.649148401182162e-05
	language	1.4127422205154051e-05
	trial court	9.546628983600831e-06
	finding	9.210634647586383e-06
	conclusion	8.68472816198529e-06
	order	7.525552338775638e-06
	J.	1.0887065817552456e-06
	Idaho	9.888555004485038e-07
	argument	8.900174688574319e-07
	U.S. Patent	8.591648935993591e-07
	matter	2.231622590407725e-07
	evidence	1.2554496016031834e-07
	law	1.0935537133313512e-07
	question	7.839993829494068e-08
	fact issue	9.211940174375292e-09
	prior art	7.240171618258445e-13
	Appeals	0.0
	District Court	0.0
